in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Morphotek and Qualitest and resignations at Sigma-Aldrich and GenVec.
Contract research organisation (CRO) Quintiles Transnational has boosted its UK marketing teams through a deal with Nycomed but is planning cutbacks at US operations in RTP.
US CMO Contract Pharmaceuticals (CPL) to close Buffalo plant by the end of 2011 on weak demand it attributes to pharmaceutical industry outsourcing cuts in downturn.
Invida has acquired a stake in Indonesia-based MUGI, giving it the local manufacturing presence needed to offer partners access to “a vast untapped market”.
CeeTox has acquired laboratory assets and hired staff from ADMETRx, which has ceased operations, as part of its strategy of establishing itself as an in vitro services leader.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Ricerca Biosciences, Trialytics, CeeTox and Firecrest Clinical.
The US FDA should change its disclosure policy relating to manufacturing site inspections according to new draft recommendations by the Department of Health and Human Services (HHS) Transparency taskforce.
Eisai has opened a $100m (€81m), 65,000 sq ft commercial manufacturing and drug development site for intravenous treatments in Research Triangle Park (RTP), North Carolina, US.
Contract research organisation (CRO) Chiltern says new Australia and Singapore offices are a natural progression for its contract research business in the Asia-Pacific region.
An increase in demand for rayon fabric in China has led to higher prices for microcrystalline cellulose, an excipient for pharmaceuticals and a stabilizer for foods, drinks and personal care products.
CRO Quintiles says Southern California Permanente Medical Group (SCPMG) partnership will improve patient recruitment and, ultimately, accelerate the drug development process.
Encorium has posted a $1.9m (€1.6m) operating loss in the first quarter, with contract cancellations and reduced new business driving net revenues down by almost 34 per cent.
India and Thailand have requested the WHO ends its involvement with IMPACT, which the countries believe has conflicts of interest, and begin a programme focused on quality, safety and efficacy.
Pfizer plans to close eight manufacturing sites and reduce operations at a further six by the end of 2015, leading to 6,000 job losses, as part of its reorganisation after acquiring Wyeth.
Johnson Matthey is to manufacture the active pharmaceutical ingredient (API) in KP201, a pain drug developed by KemPharm, as part of a risk-and-reward sharing partnership.
Concerns about the quality and capabilities of Baxter’s manufacturing operations have led to Halozyme issuing a notice of breach and stating it may terminate their Hylenex relationship.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Covance, WuXi, INC Research, Catalent and Warnex.
Eurand says Zenpap important to Q1 growth that recent FDA move provides the drug with significant potential for further expansion in cystic fibrosis (CF) market
Operating income at Medidata grew in the first quarter, underpinned by record bookings by contract research organisations (CRO) and rising revenues from Asia Pacific.
Parexel has opened two offices in China, expanding its presence in Asia Pacific to 17 sites, as part of efforts to provide cheaper, faster drug development services.
Microfluidics has posted an operating income of $106,000 (€84,000) in its results, the third consecutive quarter of profit, and is looking to expand products and services to continue growth.
Increasingly complex clinical trials are making it difficult for biopharm companies to make time and cost savings and improve patient recruitment and retention, according to a report.
Beike Biotechnology has opened a stem cell storage and processing facility at the 20,000 sq m regenerative medicine base in China, furthering the nation’s development in the field.
Kuehne + Nagel is providing Boehringer Ingelheim with temperature-controlled road transportation of medical products to Czech Republic, Poland, Hungary, Greece and Croatia.
A US Pharmacopeial Convention (USP) advisory panel has issued recommendations intended to improve drug compliance and minimise misuse by standardising prescription medication labels.
Covance has established a Discovery and Translational Services unit, integrating a number of existing operations, to foster greater scientific and technical collaboration.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Quintiles, ClinTec, Novasep, SCM and GVK.
A 38 per cent increase in revenues helped PDI cut its operating loss to $1.7m (€1.3m) in the first quarter, furthering the contract sales provider’s goal of achieving profitability by the end of the year.
Administration of Levitra (vardenafil) can increase Herceptin (trastuzumab) delivery to brain metastases, but not surrounding healthy tissue, increasing survival in mice, according to research.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at the EMA, SCM Pharma, Silence Therapeutics and Akrimax Pharmaceuticals.
Johnson Controls has secured a five year global contract to provide GlaxoSmithKline (GSK) with workplace services, such as energy management and technical and engineering support.
Albany Molecular Research (AMRI) says Q1 decline is due to “soft” demand for contract manufacturing services and trial materials, but is still confident of full-year growth.